Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Endoscopy is important for the diagnosis and treatment of acute upper gastrointestinal bleeding (AUGIB), especially acute variceal bleeding (AVB), in patients with liver cirrhosis. However, the optimal timing of endoscopy remains controversial, primarily because the currently available evidence is of poor quality, and the definition of early endoscopy is also very heterogeneous among studies. Herein, a multicenter randomized controlled trial (RCT) is performed to explore the impact of timing of endoscopy on the outcomes of cirrhotic patients with AVB.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• patients with AUGIB which is highly suspected to be caused by gastroesophageal variceal rupture;

• patients with a diagnosis of liver cirrhosis based on imaging and pathology;

• patients and/or their relatives who sign informed consents;

• patients' age ≥18 years.

Locations
Other Locations
China
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
RECRUITING
Shenyang
Contact Information
Primary
Xingshun Qi, MD
xingshunqi@126.com
18909881019
Backup
Xingshun Qi, MD
xingshunqi@126.com
Time Frame
Start Date: 2024-09-04
Estimated Completion Date: 2026-12
Participants
Target number of participants: 368
Treatments
Experimental: Early endoscopy group
Intervention of endoscopy is within 12 hours after admission
Active_comparator: Delayed endoscopy group
Intervention of endoscopy is within 12-24 hours after admission
Related Therapeutic Areas
Sponsors
Leads: General Hospital of Shenyang Military Region

This content was sourced from clinicaltrials.gov

Similar Clinical Trials